Effect of mTOR inhibitors in nude mice with endometrial carcinoma and variable PTEN expression status.
about
Effect of Momordica charantia protein on proliferation, apoptosis and the AKT signal transduction pathway in the human endometrial carcinoma Ishikawa H cell line in vitro.MicroRNA-340 Inhibits Tumor Cell Proliferation and Induces Apoptosis in Endometrial Carcinoma Cell Line RL 95-2.DJ-1 Expression in Cervical Carcinoma and its Effects on Cell Viability and ApoptosisRelationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis.Y-27632 Increases Sensitivity of PANC-1 Cells to EGCG in Regulating Cell Proliferation and MigrationLower Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Promotes the Proliferation and Migration of Endometrial Carcinoma.Locked nucleic acid-inhibitor of miR-205 decreases endometrial cancer cells proliferation in vitro and in vivo.Effect of miR-106b on Invasiveness of Pituitary Adenoma via PTEN-PI3K/AKT.Up-Regulation of Angiotensin-Converting Enzyme (ACE) Enhances Cell Proliferation and Predicts Poor Prognosis in Laryngeal CancermTOR inhibitors in urinary bladder cancer.Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway.Progression inference for somatic mutations in cancer.Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.A guide for endometrial cancer cell lines functional assays using the measurements of electronic impedance.
P2860
Q33684917-47A041E5-1D65-40E0-8222-98018A9699A5Q37029456-65E1AF16-5AA8-4975-B2E6-3E1C29DF1B80Q37217569-543217EE-61BD-497E-A24D-D64FDFC01640Q37261592-78F0D5FA-AD83-4B23-9E5E-AA048F497BA0Q37337818-7619573C-2936-4DCB-8E3E-B2F8033B411BQ37677195-2901757D-EA41-4ABE-83D6-26EB88EB5E9BQ37687451-F8FD4AD9-35F5-4E46-9A4E-1D9D3BDEA3E1Q38712436-D7252586-07DC-45BE-B6D2-A84609D8666BQ38734603-E8127D35-BD37-4866-AD8C-E82AC205592BQ38737064-C4B34057-3055-4F72-A8D6-19ADECE8FAF0Q38739217-70CF316A-9425-4B89-9446-BB3F7E065BA2Q38793244-ED8B10EC-79CF-4B86-BD58-C0BA2EBE4F75Q42066698-DFDD8DC1-FF08-41A1-9856-BEDCA32181BBQ48228063-C9F29FD9-9C12-4855-8EB4-1C363C1BB8E3
P2860
Effect of mTOR inhibitors in nude mice with endometrial carcinoma and variable PTEN expression status.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Effect of mTOR inhibitors in n ...... riable PTEN expression status.
@ast
Effect of mTOR inhibitors in n ...... riable PTEN expression status.
@en
Effect of mTOR inhibitors in n ...... riable PTEN expression status.
@nl
type
label
Effect of mTOR inhibitors in n ...... riable PTEN expression status.
@ast
Effect of mTOR inhibitors in n ...... riable PTEN expression status.
@en
Effect of mTOR inhibitors in n ...... riable PTEN expression status.
@nl
prefLabel
Effect of mTOR inhibitors in n ...... riable PTEN expression status.
@ast
Effect of mTOR inhibitors in n ...... riable PTEN expression status.
@en
Effect of mTOR inhibitors in n ...... riable PTEN expression status.
@nl
P2860
P356
P1476
Effect of mTOR inhibitors in n ...... riable PTEN expression status.
@en
P2093
Li-rong Meng
Pedro Fong
P2860
P304
P356
10.12659/MSMBR.892514
P577
2014-09-30T00:00:00Z